Skip to menu Skip to content Skip to footer

2012

Conference Publication

Inosine Triphosphastase (ITPA) Variants Predict Treatment-Induced Anemia, Ribavirin Dose-Reduction and Need for Erythropoietin Support During Peginterferon/Ribavirin Therapy for Chronic HCV

Clark, Paul J., Aghemo, Alessio, Degasperi, Elisabetta, Galmozzi, Enrico, Thompson, Alexander J., Patel, Keyur, Rumi, Maria Grazia, Prati, G. and Colombo, Massimo (2012). Inosine Triphosphastase (ITPA) Variants Predict Treatment-Induced Anemia, Ribavirin Dose-Reduction and Need for Erythropoietin Support During Peginterferon/Ribavirin Therapy for Chronic HCV. Digestive Disease Week (DDW), San Diego Ca, May 19-22, 2012. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC.

Inosine Triphosphastase (ITPA) Variants Predict Treatment-Induced Anemia, Ribavirin Dose-Reduction and Need for Erythropoietin Support During Peginterferon/Ribavirin Therapy for Chronic HCV

2012

Journal Article

Host genomics and HCV treatment response

Clark, Paul J. and Thompson, Alexander J. (2012). Host genomics and HCV treatment response. Journal of Gastroenterology and Hepatology, 27 (2), 212-222. doi: 10.1111/j.1440-1746.2011.06918.x

Host genomics and HCV treatment response

2012

Conference Publication

Analysis of Genotype 1 Hcv Adaptation to Host Il28B Polymorphism - Evidence for Viral Innate Immune Escape Patterns

Thompson, A. J., Clark, P. J., Patel, K., Tillmann, H. L., Urban, T. J., Shianna, K. V., Goldstein, D. B., McHutchison, J. G., Muir, A. J., James, I., Lucas, M. and Gaudieri, S. (2012). Analysis of Genotype 1 Hcv Adaptation to Host Il28B Polymorphism - Evidence for Viral Innate Immune Escape Patterns. 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Barcelona Spain, Apr 18-22, 2012. AMSTERDAM: ELSEVIER SCIENCE BV. doi: 10.1016/S0168-8278(12)60942-8

Analysis of Genotype 1 Hcv Adaptation to Host Il28B Polymorphism - Evidence for Viral Innate Immune Escape Patterns

2012

Conference Publication

MRECIST Criteria Response to Pretransplant Transarterial Chemoembolization (TACE) is Predictive of Improved Survival for Patients With HCV Undergoing Liver Transplantation for Hepatocellular Carcinoma (HCC)

Clark, Paul J., Heimbach, Julie K., Rosen, Charles B., Sanchez, William, Gores, Gregory J., Muir, Andrew J. and Charlton, Michael R. (2012). MRECIST Criteria Response to Pretransplant Transarterial Chemoembolization (TACE) is Predictive of Improved Survival for Patients With HCV Undergoing Liver Transplantation for Hepatocellular Carcinoma (HCC). Digestive Disease Week (DDW), San Diego Ca, May 19-22, 2012. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC.

MRECIST Criteria Response to Pretransplant Transarterial Chemoembolization (TACE) is Predictive of Improved Survival for Patients With HCV Undergoing Liver Transplantation for Hepatocellular Carcinoma (HCC)

2012

Conference Publication

Exploration of Serum Adipocytokine Associations with Il28B Genotype in Chronic Hepatitis C

Clark, P. J., Thompson, A. J., Tillmann, H. L., Jazwinski, A., Naggie, S., Muir, A. J. and Patel, K. (2012). Exploration of Serum Adipocytokine Associations with Il28B Genotype in Chronic Hepatitis C. 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Barcelona Spain, Apr 18-22, 2012. AMSTERDAM: ELSEVIER SCIENCE BV. doi: 10.1016/S0168-8278(12)60896-4

Exploration of Serum Adipocytokine Associations with Il28B Genotype in Chronic Hepatitis C

2012

Journal Article

The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic Hepatitis C infection

Clark, Paul J., Thompson, Alexander J., Zhu, Qianqian, Vock, David M., Zhu, Mingfu, Patel, Keyur, Harrison, Stephen A., Naggie, Susanna, Ge, Dongliang, Tillmann, Hans L., Urban, Thomas J., Shianna, Kevin, Fellay, Jacques, Goodman, Zachary, Noviello, Stephanie, Pedicone, Lisa D., Afdhal, Nezam, Sulkowski, Mark, Albrecht, Janice K., Goldstein, David B., McHutchison, John G. and Muir, Andrew J. (2012). The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic Hepatitis C infection. Digestive Diseases and Sciences, 57 (8), 2213-2221. doi: 10.1007/s10620-012-2171-y

The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic Hepatitis C infection

2012

Conference Publication

Optimizing ribavirin dose is critical for sustained viral response in patients with thalassemia major treated for chronic hepatitis C

Clark, Paul J., Santoro, Rosanna, Piazzolla, Valeria, Mottola, Leonardo, Bacca, D., Dello Iacono, N., Grimaldi, Salvatore, Quarta, Antonella, Urban, Thomas J., Naggie, Susanna, Patel, Keyur, Thompson, Alexander J., Muir, Andrew J. and Mangia, Alessandra (2012). Optimizing ribavirin dose is critical for sustained viral response in patients with thalassemia major treated for chronic hepatitis C. 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Boston Ma, Nov 09-13, 2012. HOBOKEN: WILEY-BLACKWELL.

Optimizing ribavirin dose is critical for sustained viral response in patients with thalassemia major treated for chronic hepatitis C

2011

Journal Article

Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C

Tillmann, Hans L., Patel, Keyur, Muir, Andrew J., Guy, Cynthia D., Li, Josephine H., Lao, Xiang Qian, Thompson, Alexander, Clark, Paul J., Gardner, Stephen D., McHutchison, John G. and McCarthy, Jeanette J. (2011). Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C. Journal of Hepatology, 55 (6), 1195-1200. doi: 10.1016/j.jhep.2011.03.015

Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C

2011

Journal Article

Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis C

Golden-Mason, Lucy, Bambha, Kiran M., Cheng, Linling, Howell, Charles D., Taylor, Milton W., Clark, Paul J., Afdhal, Nezam and Rosen, Hugo R. (2011). Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis C. Hepatology, 54 (5), 1559-1569. doi: 10.1002/hep.24556

Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis C

2011

Conference Publication

PREDICTORS OF CONSENT TO PHARMACOGENOMICS TESTING IN THE IDEAL STUDY

Jazwinski, Alison, Clark, Paul J., Thompson, Alexander J., Gordon, Stuart C., Lawitz, Eric, McCone, Jonathan, Noviello, Stephanie, Brass, Clifford A., Pedicone, Lisa, Albrecht, Janice K., Sulkowski, Mark S., Muir, Andrew J. and Jazwinski, Alison (2011). PREDICTORS OF CONSENT TO PHARMACOGENOMICS TESTING IN THE IDEAL STUDY. 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San Francisco Ca, Nov 04-08, 2011. MALDEN: WILEY-BLACKWELL.

PREDICTORS OF CONSENT TO PHARMACOGENOMICS TESTING IN THE IDEAL STUDY

2011

Journal Article

Characterization of serum proteins associated with IL28B genotype among patients with chronic hepatitis C

Cyr, Derek D., Lucas, Joseph E., Thompson, J. Will, Patel, Keyur, Clark, Paul J., Thompson, Alexander, Tillmann, Hans L., McHutchison, John G., Moseley, M. Arthur and McCarthy, Jeanette J. (2011). Characterization of serum proteins associated with IL28B genotype among patients with chronic hepatitis C. PLoS One, 6 (7) e21854, 1-6. doi: 10.1371/journal.pone.0021854

Characterization of serum proteins associated with IL28B genotype among patients with chronic hepatitis C

2011

Journal Article

Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients

Patel, Keyur, Thompson, Alexander J., Chuang, Wan-Long, Lee, Chuan-Mo, Peng, Chen-Yuan, Shanmuganathan, Ganesananthan, Thongsawat, Satawat, Tanwandee, Tawesak, Mahachai, Varocha, Pramoolsinsap, Chutima, Cho, Mong, Han, Kwang Hyup, Shah, Samir R., Foster, Graham R., Clark, Paul J., Pulkstenis, Erik, Subramanian, G. Mani and McHutchison, John G. (2011). Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients. Journal of Gastroenterology and Hepatology (Australia), 26 (7), 1182-1188. doi: 10.1111/j.1440-1746.2011.06722.x

Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients

2011

Conference Publication

Phosphodiesterase Polymorphisms May Be Associated with Baseline Thyroid Stimulating Hormone (Tsh) and Peginterferon Treatment Induced Hypothyroidism in Patients with Chronic Hepatitis C

Clark, P. J., Thompson, A. J., Zhu, M., Ge, D., Shianna, K., Tillmann, H. L., Patel, K., Urban, T., Singh, A., Sulkowski, M., Afdhal, N., Jacobson, I., Esteban, R., Poordad, F., Lawitz, E., McCone, J., Shiffman, M. L., Galler, G., Lee, W. M., Reindollar, R., King, J., Kwo, P., Ghalib, R., Freilich, B., Nyberg, L., Noviello, S., Bopari, N., Koury, K., Pedicone, L. D. ... Muir, A. J. (2011). Phosphodiesterase Polymorphisms May Be Associated with Baseline Thyroid Stimulating Hormone (Tsh) and Peginterferon Treatment Induced Hypothyroidism in Patients with Chronic Hepatitis C. 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Berlin Germany, 2011. AMSTERDAM: ELSEVIER SCIENCE BV. doi: 10.1016/S0168-8278(11)60129-3

Phosphodiesterase Polymorphisms May Be Associated with Baseline Thyroid Stimulating Hormone (Tsh) and Peginterferon Treatment Induced Hypothyroidism in Patients with Chronic Hepatitis C

2011

Conference Publication

PREDICTING PEGINTERFERON-alpha AND RIBAVIRIN TREATMENT RESPONSE IN GENOTYPE 1 HCV PATIENTS - SIMPLE NOMOGRAMS TO SUPPORT CLINICIANS

Thompson, Alexander J., Clark, Paul J., Vock, David M., Pfeiffer, Ruth, Tillmann, Hans L., Patel, Keyur, Naggie, Susanna, Poordad, F. Fred, Nyberg, Lisa M., Noviello, Stephanie, Pedicone, Lisa, Brass, Clifford A., Albrecht, Janice K., Goldstein, David B., McHutchison, John G., O'Brien, Thomas R., Sulkowski, Mark S. and Muir, Andrew J. (2011). PREDICTING PEGINTERFERON-alpha AND RIBAVIRIN TREATMENT RESPONSE IN GENOTYPE 1 HCV PATIENTS - SIMPLE NOMOGRAMS TO SUPPORT CLINICIANS. 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San Francisco Ca, Nov 04-08, 2011. MALDEN: WILEY-BLACKWELL.

PREDICTING PEGINTERFERON-alpha AND RIBAVIRIN TREATMENT RESPONSE IN GENOTYPE 1 HCV PATIENTS - SIMPLE NOMOGRAMS TO SUPPORT CLINICIANS

2011

Conference Publication

Thyroid Stimulating Hormone (TSH) and Peginterferon Treatment Induced Hypothyroidism May Be Associated With Phosphodiesterase Polymorphisms in Patients With Chronic Hepatitis C

Clark, Paul, Thompson, Alexander J., Zhu, Mingfu, Ge, Dongliang, Shianna, Kevin, Tillmann, Hans L., Patel, Keyur, Urban, Thomas, Singh, Abanish, Sulkowski, Mark, Afdhal, Nezam, Jacobson, Ira M., Esteban, Rafael, Poordad, Fred, Lawitz, Eric J., McCone, Jonathan, Shiffman, Mitchell L., Galler, Greg, Lee, William M., Reindollar, Robert W., King, John W., Kwo, Paul Y., Ghalib, Reem H., Freilich, Bradley, Nyberg, Lisa M., Noviello, Stephanie, Boparai, Navdeep, Koury, Kenneth, Pedicone, Lisa D. and Brass, Clifford A. (2011). Thyroid Stimulating Hormone (TSH) and Peginterferon Treatment Induced Hypothyroidism May Be Associated With Phosphodiesterase Polymorphisms in Patients With Chronic Hepatitis C. Conference on Digestive Disease Week 2011, Chicago Il, May 07-10, 2011. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC.

Thyroid Stimulating Hormone (TSH) and Peginterferon Treatment Induced Hypothyroidism May Be Associated With Phosphodiesterase Polymorphisms in Patients With Chronic Hepatitis C

2011

Conference Publication

Nk Inhibitory Receptor Expression Associated with Treatment Failure and Il-28B Genotype in Patients with Chronic Hepatitis C

Golden-Mason, Lucy, Bambha, Kiran, Cheng, Linling, Howell, Charles D., Taylor, Milton W., Clark, Paul J., Afdhal, Nezam H. and Rosen, Hugo R. (2011). Nk Inhibitory Receptor Expression Associated with Treatment Failure and Il-28B Genotype in Patients with Chronic Hepatitis C. 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San Francisco Ca, Nov 04-08, 2011. MALDEN: WILEY-BLACKWELL.

Nk Inhibitory Receptor Expression Associated with Treatment Failure and Il-28B Genotype in Patients with Chronic Hepatitis C

2011

Journal Article

Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR

Thompson, Alexander J., Santoro, Rosanna, Piazzolla, Valeria, Clark, Paul J., Naggie, Susanna, Tillmann, Hans L., Patel, Keyur, Muir, Andrew J., Shianna, Kevin V., Mottola, Leonardo, Petruzzellis, Daniela, Romano, Mario, Sogari, Fernando, Facciorusso, Domenico, Goldstein, David B., McHutchison, John G. and Mangia, Alessandra (2011). Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR. Hepatology, 53 (2), 389-395. doi: 10.1002/hep.24068

Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR

2011

Conference Publication

Dysregulation of Host Innate Immunity in Hcv Genotype 1 Infected Il28B Ct/tt Haplotype Patients with Depressed Viral Kinetics and Therapeutic Response

Naggie, S., Osinusi, A., Katsounas, A., Lempicki, R., Herrmann, E., Shivakumar, B., Thompson, A., Clark, P., Patel, K., Muir, A., Mchutchison, J., Goldstein, D., Schlaak, J., Masur, H., Polis, M. and Kottilil, S. (2011). Dysregulation of Host Innate Immunity in Hcv Genotype 1 Infected Il28B Ct/tt Haplotype Patients with Depressed Viral Kinetics and Therapeutic Response. 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Berlin Germany, 2011. AMSTERDAM: ELSEVIER SCIENCE BV. doi: 10.1016/S0168-8278(11)61336-6

Dysregulation of Host Innate Immunity in Hcv Genotype 1 Infected Il28B Ct/tt Haplotype Patients with Depressed Viral Kinetics and Therapeutic Response

2011

Conference Publication

The Cost-Effectiveness of a Telaprevir-Inclusive Regimen as Initial Therapy for Genotype 1 Hepatitis C Infection in Individuals with the Cc Il-28B Polymorphism

Gellad, Ziad F., Naggie, Susanna, Reed, Shelby D., Clark, Paul J., Thompson, Alex J., Schulman, Kevin A. and Muir, Andrew J. (2011). The Cost-Effectiveness of a Telaprevir-Inclusive Regimen as Initial Therapy for Genotype 1 Hepatitis C Infection in Individuals with the Cc Il-28B Polymorphism. 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San Francisco Ca, Nov 04-08, 2011. MALDEN: WILEY-BLACKWELL.

The Cost-Effectiveness of a Telaprevir-Inclusive Regimen as Initial Therapy for Genotype 1 Hepatitis C Infection in Individuals with the Cc Il-28B Polymorphism

2011

Conference Publication

Metabolomic Analysis Demonstrates Hepatitis C Virus Genotypes G2/3 Selectively Perturb Distal Steps in Cholesterol Biosynthesis

Clark, Paul J., Thompson, Alexander J., Vock, David M., Kratz, Lisa E., Tolun, Adviye A., Zhang, Hao Yue, Muir, Andrew J., Subramanian, Mani, McHutchison, John G., Millington, David S., Kelley, Richard I. and Patel, Keyur (2011). Metabolomic Analysis Demonstrates Hepatitis C Virus Genotypes G2/3 Selectively Perturb Distal Steps in Cholesterol Biosynthesis. 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San Francisco Ca, Nov 04-08, 2011. MALDEN: WILEY-BLACKWELL.

Metabolomic Analysis Demonstrates Hepatitis C Virus Genotypes G2/3 Selectively Perturb Distal Steps in Cholesterol Biosynthesis